Barclays’ double upgrade from an above-average return firm, combined with rising EPS estimates and new institutional accumulation, outweighs recent insider selling. Position for upside toward $250 over next 60 days, especially if next earnings (July 20) beats.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 23 $281.89entry
- T+1 · 7mo ago −1.71%α −2.50% · $277.06
- T+5 · 7mo ago −4.49%α −5.97% · $269.22
- T+20 · 6mo ago +8.16%α +3.52% · $304.88
- T+60 · 4mo ago +0.76%α −4.16% · $284.02
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Barclays executed a rare double upgrade from Underweight to Equal-Weight with a 43% price target increase to $250, now 5.7% above current price of $236.31. The broader consensus remains mixed at 52% Buy-rated (16 of 31 analysts), with a mean PT of $228.71, Barclays' target sits in the 84th percentile. Firm has 60% accuracy on 5 calls, above its 54% historical rate, and average return of 8.6%. Four upgrades in 30 days signal improving sentiment, while EPS estimates are rising: +3 revisions up vs. 1 down in past month. Contrarian signal diverges from Goldman Sachs' maintained Sell rating and B of A's trim of position by 39.4%. Bottom line: high-conviction upgrade from above-average firm amid strengthening fundamentals and institutional accumulation.
Impact Score
Consensus & Targets
Of 31 analysts, 16 rate it Buy or Strong Buy (52%), 22 Hold (71% including Hold), 6 Sell or Strong Sell (19%). Consensus direction is neutral-biased with no clear momentum; however, 4 of the last 5 actions were upgrades, indicating recent positive drift.
Price target mean is $228.71, median $235, range $175–$275. Current price at $236.31 implies 0.7% upside to mean. Barclays' $250 target is 9.3% above mean and 5.7% above current price, placing it in the top tier of bullish calls. Rosenblatt's $330 and Baird's $300 remain the most aggressive.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-23 | Barclays | upgrade | Equal-Weight | $250.00 |
| 2026-04-23 | Rosenblatt | maintain | Buy | $330.00 |
| 2026-04-23 | Baird | maintain | Outperform | $300.00 |
| 2026-04-23 | Goldman Sachs | maintain | Sell | $200.00 |
| 2026-04-23 | B of A Securities | upgrade | Buy | $320.00 |
| 2026-04-17 | Mizuho | upgrade | Neutral | $215.00 |
| 2026-04-09 | Stifel | upgrade | Buy | $250.00 |
| 2026-02-23 | Cantor Fitzgerald | maintain | Neutral | $250.00 |
| 2026-02-05 | Rosenblatt | maintain | Buy | $240.00 |
| 2026-01-28 | Jefferies | maintain | Hold | $210.00 |
4 upgrades and 0 downgrades in the past 30 days. EPS estimates are trending up: +3 revisions in the last 30 days vs. 1 down for current year (0y), and +3 up vs. 0 down for next year (+1y). Current quarter (0q) saw 2 upward revisions, 1 downward. No revisions in past 7 days.
Firm Track Record: Barclays
Barclays accuracy: 54% on 6761 calls | avg return: 3.9%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Baird | 80% | 4/5 | 10.2% | top tier |
| JP Morgan | 80% | 4/5 | 8.6% | top tier |
| Evercore ISI Group | 75% | 3/4 | 9.3% | top tier |
| Keybanc | 67% | 2/3 | 1.6% | top tier |
| Benchmark | 67% | 6/9 | 2.8% | top tier |
| Truist Securities | 67% | 6/9 | 3.8% | top tier |
| Stifel | 67% | 4/6 | 10.9% | top tier |
| Jefferies | 67% | 2/3 | 8.6% | top tier |
| Cantor Fitzgerald | 64% | 7/11 | 4.1% | top tier |
| Barclays | 60% | 3/5 | 8.6% | above average |
Barclays has 60% accuracy (3 of 5 calls correct), above its long-term 54% (3,624 of 6,761) average, with an 8.6% average return on rated stocks. Among 15 firms, Barclays ranks 10th in accuracy but 4th in average return. Top performers include Stifel (67%, 10.9% return) and Baird (80%, 10.2%).
Earnings Estimates
Next earnings: Jul 20, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $1.81 | $1.59 to $2.10 | $5.2B | ↑0 ↓0 |
| 0y | $6.46 | $5.85 to $7.28 | $19.6B | ↑1 ↓0 |
| +1y | $7.74 | $6.88 to $9.71 | $21.7B | ↑2 ↓0 |
| 0q | $1.58 | $1.49 to $1.66 | $4.9B | ↑1 ↓0 |
Cross-Platform Signals
Signal diverges from insider and congressional activity: Rep. Kevin Hern sold $500K–$1M on March 18. Institutionally, BANK OF AMERICA CORP trimmed position by 39.4%, but Norges Bank re-entered with $2.5B stake and Renaissance Technologies initiated $137M position. Short interest remains elevated at 56.0% short ratio, suggesting ongoing bearish overhang despite recent upgrades.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
31 reports on TXN
5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +11.96% at T+5 after the Oct 21, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $312.48 Now $293.06 −6.21% settles Dec 11
- Nov 9, 20266d ago 8-K Neutral 3/10 Entry $300.52 Now $293.06 −2.48% settles Dec 9
- Oct 30, 202617d ago Insider Cluster Neutral 3/10 Entry $302.02 Now $293.06 −2.97% settles Dec 1
- Oct 29, 202618d ago Insider Cluster Neutral 2/10 Entry $300.84 Now $293.06 −2.59% settles Nov 30
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $312.94 Now $293.06 −6.35% settles Nov 27
- Oct 27, 202619d ago 424B5 Neutral 4/10 Entry $309.83 Now $293.06 −5.41% settles Nov 25
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $308.91 Now $293.06 −5.13% settles Nov 24
- Oct 26, 202621d ago 424B5 Neutral 4/10 Entry $298.12 Now $293.06 −1.70% settles Nov 23
- Oct 22, 202625d ago ANALYST-UPGRADE Bullish 5/10 Entry $284.69 Now $293.06 +2.94% settles Nov 20
- Oct 21, 202626d ago 8-K Bullish 6/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers